|
| |
LEO PharmaLEO Pharma is a globally, leading pharmaceutical company within Dermatology and Critical Care.
We maintain a strong focus on developing, manufacturing and marketing safe and efficacious drugs for treating psoriasis and other skin diseases as well as thromboembolic disorders.
LEO Pharma is an independent pharmaceutical company 100 % owned by the LEO Foundation and represented in more than 90 countries and has around 3,000 employees around the world; 1,200 of these in Ballerup, Denmark.
| Contact Details: |
| Industriparken 55 · |
| Ballerup |
| |
| DK-2750 |
| Denmark |
| Tel: | 45 4494 5888 |
| Fax: | 45 7226 3321 |
| Email: | leo.group@leo-pharma.com |
| WWW: | www.leopharma.com/
|
| |
Recent Publications by LEO Pharma: |  |
Induced keratinocyte hyper-proliferation in alpha2beta1 integrin transgenic mice results in systemic immune cell activation.
alpha2beta1 integrins are normally confined to the proliferating basal... | 21st October, 2009
| Dermatology Section, Department of Pharmacology, Discovery, LEO Pharma,
| Int Immunopharmacol. 2009 Oct 17.
DOI Direct Link |
Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles.
Solid lipid nanoparticles (SLN) show promise as a drug delivery system for... | 20th October, 2009
| LEO Pharma A/S, Industriparken 55, DK-2750 Ballerup, Denmark; Faculty of
| Int J Pharm. 2009 Oct 25.
DOI Direct Link |
Regulatory T cells control VEGF-dependent skin inflammation.
Transgenic mice expressing vascular endothelial growth factor (VEGF) under... | 23rd June, 2009
| Department of Pharmacology, Section of Dermatology, Discovery, LEO Pharma
| J Invest Dermatol. 2009 Jun;129(6):1437-45. Epub 2008 Nov 27.
DOI Direct Link |
TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis.
Psoriasis is a common chronic inflammatory skin disease, characterized by... | 20th June, 2009
| Section of Dermatology, Department of Pharmacology, LEO Pharma A/S,
| Int Immunol. 2008 Aug;20(8):1097-106. Epub 2008 Jun 25.
DOI Direct Link |
Translational dermatology in drug discovery: perspectives for integrating humanized xenograft models and experimental clinical studies.
Application of humanized xenotransplantation disease models and... | 20th September, 2008
| Biological Research, Discovery, LEO Pharma, 55 Industriparken, DK-2750
| Drug Discov Today. 2008 Mar;13(5-6):240-6. Epub 2007 Nov 26.
DOI Direct Link |
→View more LEO Pharma research publications. |
Press Releases on LEO Pharma:
|
 |
| Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2009 |
9th November, 2009 |
Warner Chilcott plc |
ARDEE, Ireland, Nov. 9 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced its results for the quarter ended September 30, 2009. Revenue in the quarter ended September 30,
|
| Life Sciences Organizations Choose Oracle to Accelerate and Simplify Clinical Trial Data Collection |
21st January, 2009 |
Oracle |
REDWOOD SHORES, Calif., Jan. 21 /PRNewswire-FirstCall/ --
News Facts
-- Organizations spanning the life sciences industry -- including
biopharmaceutical companies, contract research
|
| Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2008 and Updates 2008 Full Year Guidance |
10th November, 2008 |
Warner Chilcott Limited |
Growth of promoted products and reduced operating costs continue to drive solid earnings growth.
ST. DAVID'S, Bermuda, Nov. 10 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX)
|
| Unique New Gel Combination Provides Relief For Distressing Scalp Condition |
9th November, 2008 |
|
LONDON, November 10 /PRNewswire/ -- A new, once-daily treatment gel is available on prescription today for
the itching, flaking and soreness caused by the common condition scalp
psoriasis. Xamiol(R)
|
| Warner Chilcott Announces New Information in USPTO Reexamination of TACLONEX Patent |
24th July, 2008 |
Warner Chilcott Limited |
ST. DAVID'S, Bermuda, July 24 /PRNewswire-FirstCall/ -- Warner Chilcott
Limited (Nasdaq: WCRX) announced today that LEO Pharma A/S ("LEO Pharma") has
received a Right of Appeal
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 14 individuals from LEO Pharma using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 343 times since April 2007, the link to the organisation's website has been followed 36 times Search for more companies in Ballerup Search for more companies in This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for LEO Pharma |
